BSEM BIOSTEM TECHNOLOGIES INC revenue, earnings and financials
For the quarter ended June 30, 2026, BIOSTEM TECHNOLOGIES INC reported revenue of $7.90M (down 27.9% from a year earlier), net income of −$8.97M and diluted EPS of −$0.52; for the fiscal year ended December 2025 revenue was $47.5M, down 31.8% on the year before.
BSEM annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $47.5M, gross profit $44.4M, operating income −$689K, net income −$6.58M (margin -13.9%), EPS −$0.39
- Fiscal year ended Dec 2024: revenue $69.7M, gross profit $55.9M, operating income $31.1M, net income $31.0M (margin 44.5%), EPS $1.43
BSEM quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $7.90M (down 27.9% year over year), net income −$8.97M, EPS −$0.52
- Quarter ended Jun 30, 2025: revenue $11.0M, net income $10.6K, EPS $0.00
BSEM cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $9.94M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow $24.5M, share buybacks n/a
BSEM balance sheet
- Jun 30, 2026: cash $6.96M, total assets $48.8M, total liabilities $21.2M, shareholders' equity $27.6M
- Dec 31, 2025: cash $29.5M, total assets $50.0M, total liabilities $10.9M, shareholders' equity $39.1M
- Dec 31, 2024: cash $22.8M, total assets $58.3M, total liabilities $18.3M, shareholders' equity $40.0M
What is BSEM's revenue?
BIOSTEM TECHNOLOGIES INC reported $47.5M of revenue for the fiscal year ended December 2025.
Is BSEM profitable?
No. BIOSTEM TECHNOLOGIES INC lost $6.58M in its latest fiscal year.